EIDX
Eidos Therapeutics, Inc. Common Stock
EIDX
EIDX
Delisted
EIDX was delisted on the 25th of January, 2021.
89 hedge funds and large institutions have $617M invested in Eidos Therapeutics, Inc. Common Stock in 2020 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 29 increasing their positions, 30 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
50% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 26
Holders
89
Holding in Top 10
4
Calls
$5.4M
Puts
$4.34M
Top Buyers
| 1 | +$29.6M | |
| 2 | +$10.4M | |
| 3 | +$8.07M | |
| 4 |
Invesco
Atlanta,
Georgia
|
+$4.77M |
| 5 |
BlackRock
New York
|
+$4.59M |
Top Sellers
| 1 | -$10.4M | |
| 2 | -$9.62M | |
| 3 | -$6.18M | |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$3.49M |
| 5 |
CAC
Cowen and Company
New York
|
-$2.69M |